世界の肺がん治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4444 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法、化学療法、放射線療法、その他）、用途別市場規模（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・肺がん治療薬の種類別市場規模と予測2016-2027（標的療法、免疫療法、化学療法、放射線療法、その他） ・肺がん治療薬の用途別市場規模と予測2016-2027（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC）） ・肺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・肺がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Eli Lilly and Company、GlaxoSmithKline、Roche、Boehringer Ingelheim GmbH、Pfizer、Sanofi S.A.、Bristol-Myers Squibb、Novartis、Agennix AG） ・結論

Market Analysis and Insights: Global Lung Cancer Therapeutics Market
The global Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Therapeutics market.

Global Lung Cancer Therapeutics Scope and Market Size
Lung Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Therapy
Immunotherapy
Chemotherapy
Radiation Therapy
Others

Segment by Application
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Roche
Boehringer Ingelheim GmbH
Pfizer
Sanofi S.A.
Bristol-Myers Squibb
Novartis
Agennix AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Non-Small Cell Lung Cancer (NSCLC)
1.3.3 Small Cell Lung Cancer (SCLC)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Therapeutics Market Perspective (2016-2027)
2.2 Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Therapeutics Industry Dynamic
2.3.1 Lung Cancer Therapeutics Market Trends
2.3.2 Lung Cancer Therapeutics Market Drivers
2.3.3 Lung Cancer Therapeutics Market Challenges
2.3.4 Lung Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Lung Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Therapeutics Revenue
3.4 Global Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2020
3.5 Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Lung Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Lung Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Therapeutics Market Size (2016-2027)
6.2 North America Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Lung Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Lung Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Lung Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Lung Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Lung Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Lung Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Lung Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Lung Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Lung Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Lung Cancer Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Lung Cancer Therapeutics Introduction
11.2.4 Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Lung Cancer Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapeutics Introduction
11.4.4 Roche Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.5.5 Boehringer Ingelheim GmbH Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Lung Cancer Therapeutics Introduction
11.6.4 Pfizer Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Sanofi S.A. Business Overview
11.7.3 Sanofi S.A. Lung Cancer Therapeutics Introduction
11.7.4 Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.7.5 Sanofi S.A. Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Lung Cancer Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Lung Cancer Therapeutics Introduction
11.9.4 Novartis Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Agennix AG
11.10.1 Agennix AG Company Details
11.10.2 Agennix AG Business Overview
11.10.3 Agennix AG Lung Cancer Therapeutics Introduction
11.10.4 Agennix AG Revenue in Lung Cancer Therapeutics Business (2016-2021)
11.10.5 Agennix AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Others
Table 7. Global Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Lung Cancer Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Table 13. Lung Cancer Therapeutics Market Trends
Table 14. Lung Cancer Therapeutics Market Drivers
Table 15. Lung Cancer Therapeutics Market Challenges
Table 16. Lung Cancer Therapeutics Market Restraints
Table 17. Global Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Lung Cancer Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapeutics as of 2020)
Table 20. Ranking of Global Top Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lung Cancer Therapeutics Product Solution and Service
Table 24. Date of Enter into Lung Cancer Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Lung Cancer Therapeutics Product
Table 67. AstraZeneca Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Eli Lilly and Company Company Details
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Lung Cancer Therapeutics Product
Table 72. Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly and Company Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Lung Cancer Therapeutics Product
Table 77. GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Lung Cancer Therapeutics Product
Table 82. Roche Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Roche Recent Development
Table 84. Boehringer Ingelheim GmbH Company Details
Table 85. Boehringer Ingelheim GmbH Business Overview
Table 86. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product
Table 87. Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Boehringer Ingelheim GmbH Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Lung Cancer Therapeutics Product
Table 92. Pfizer Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Sanofi S.A. Company Details
Table 95. Sanofi S.A. Business Overview
Table 96. Sanofi S.A. Lung Cancer Therapeutics Product
Table 97. Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Sanofi S.A. Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Lung Cancer Therapeutics Product
Table 106. Novartis Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Agennix AG Company Details
Table 109. Agennix AG Business Overview
Table 110. Agennix AG Lung Cancer Therapeutics Product
Table 111. Agennix AG Revenue in Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Agennix AG Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Others Features
Figure 7. Global Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Non-Small Cell Lung Cancer (NSCLC) Case Studies
Figure 9. Small Cell Lung Cancer (SCLC) Case Studies
Figure 10. Lung Cancer Therapeutics Report Years Considered
Figure 11. Global Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Lung Cancer Therapeutics Market Share by Players in 2020
Figure 16. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2020
Figure 18. Global Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Therapeutics Market Share by Region (2016-2027)
Figure 40. China Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 63. Boehringer Ingelheim GmbH Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 65. Sanofi S.A. Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 68. Agennix AG Revenue Growth Rate in Lung Cancer Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---